Egypt reforms obsolete pharmaceutical pricing framework
The new framework aims to address these long-standing pressures through several measures, including price reviews linked to macroeconomic indicators.
Comment & Opinion
Danish fast-track model inspires growth in national reimbursement rates
Global systems unprepared for rising threat of invasive fungal infections
CPHI 2026: Finding the right CDMO partner in an age of consolidation
Suspected plague outbreak in Russia: public health risk lower than Covid-19
CPHI 2026: Moderna builds on its COVID-era manufacturing lessons
EASD 2026: Tirzepatide outperforms semaglutide in real-world type 2 diabetes analysis
EASD 2026: CagriSema weight loss holds at submaximal doses in REDEFINE-1 analysis
